Sagimet Biosciences has initiated its U.S. Phase 3 AURORA clinical trial for denifanstat, an oral acne treatment targeting moderate to severe cases, with topline data expected in late 2027. The company raised $115 million in October through an equity offering, boosting its cash reserves to approximately $356 million, which should fund operations through mid-2029, including potential NDA submission. Positive Phase 3 results from its Chinese partner Ascletis support the drug's efficacy and safety. Sagimet also plans to start a Phase 2 trial for another FASN inhibitor, TVB-3567, by the end of 2026.
Sagimet Biosciences shares context is provided here with Health-sector data from Pluang. For readers following Health stocks, 91 of 150 US-listed stocks rose and 53 fell today. Notable movers include AHCO at USD 7.62 with a 2.31% drop and 100% sell order activity, TAK at USD 21.30 up 2.21% with 100% buy orders, and ALNY at USD 163.03 up 1.99%. Data is as of Nov 12, 2026 19:11 WIB.
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
BofA Securities raised its price target for Royal Caribbean Group to $365, citing strong booking volumes and the company’s goal of adjusted earnings per share around $20 by 2027. The cruise operator expects 4.5% capacity growth next year and has repo...
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
